-
UTI Healthcare Fund Regular Plan Growth
Equity healthcare
Overview ( as on 08/05/25 )
NAV
₹265.44
Last change
₹-2.56 -0.01%
Fund Size (AUM)
1042.04 Cr
Performance
21.61% (5Y)
Fund Details
UTI Healthcare Fund Regular Plan Growth
as of 08/05/25
AUM
1042.04 Cr
Expense Ratio
2.25 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | 18.92% | 21.49% | 21.61% |
| BSE Healthcare TR INR | 19.22% | 20.14% | 22.45% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.65% |
Cipla Ltd |
5.81% |
Ajanta Pharma Ltd |
4.4% |
Dr Reddy's Laboratories Ltd |
4.35% |
Glenmark Pharmaceuticals Ltd |
4.07% |
Procter & Gamble Health Ltd |
3.65% |
Apollo Hospitals Enterprise Ltd |
3.57% |
Fortis Healthcare Ltd |
3.12% |
Divi's Laboratories Ltd |
3.1% |
Alkem Laboratories Ltd |
2.99% |
Sector Allocation
Healthcare |
98.81% |
Basic Materials |
1.19% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.96% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.96% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-P
Equity healthcare-
Returns
-
24.96% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.76% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.03% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
22.14% (5Y)
-
